ESC Premium Access

Congress committee e-posters choice in pharmacology and pharmacotherapy

Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacology and Pharmacotherapy
Session type: Congress Committee e-posters Choice
Date: 27 August 2021
Time: 08:00 - 20:00

Congress Session

18 presentations in this session

Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients with atrial fibrillation on direct-acting oral anticoagulants

Speaker: Mr A. Holt (Copenhagen, DK)
Thumbnail

Usage and risk with phosphodiesterase type 5 inhibitors in male patients with chronic ischemic heart disease on oral organic nitrates

Speaker: Mr A. Holt (Copenhagen, DK)
Thumbnail

PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual kinetic mechanism of action

Speaker: Mr Q. Ying (Perth, AU)
Thumbnail

Antifibrotic and anti-inflammatory effects of the selective nonsteroidal MR antagonist finerenone in preclinical pulmonary fibrosis

Speaker: Doctor M. Delbeck (Wuppertal, DE)
Thumbnail

Aspirin vs. P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation: insights from the AFIRE trial

Speaker: Assistant Professor H. Fukaya (Sagamihara, JP)
Thumbnail

Renal decline in patients with atrial fibrillation treated with rivaroxaban or warfarin: a population-based cohort study in the United Kingdom

Speaker: Doctor Y. Lenz (Berlin, DE)
Thumbnail

Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial.

Speaker: Professor L. Nicolosi (Buenos Aires, AR)
Thumbnail

Effect of genetic polymorphisms and haplotypes on the efficacy and safety of postoperative analgesia with ketoprofen in patients with coronary artery disease after cardiac surgery.

Speaker: Mr D. Shatskiy (Moscow, RU)
Thumbnail

PCSK9 inhibitors associated hyperglycemic disorders: a real world, pharmacovigilance study

Speaker: Doctor A. Goldman (Tel Hashomer, IL)
Thumbnail

Lignocaine versus opioids in coronary intervention: assessing antiplatelet activity and ticagrelor levels (LOCAL) Study

Speaker: Doctor H. Fernando (Melbourne, AU)
Thumbnail

18 speakers from this session

Mr Anders Holt

Copenhagen University Hospital - Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

Mr Anders Holt

Copenhagen University Hospital - Herlev and Gentofte Hospital, Copenhagen (Denmark)
0 follower

Mr Qidi Ying

Royal Perth Hospital, Perth (Australia)
0 follower

Doctor Martina Delbeck

, Wuppertal (Germany)
0 follower

Assistant Professor Hidehira Fukaya

Kitasato University School of Medicine, Sagamihara (Japan)
0 follower

Doctor Yanina Lenz

, Berlin (Germany)
0 follower

Professor Liliana Nicolosi

Spanish Hospital of Buenos Aires, Buenos Aires (Argentina)
0 follower

Mr Dmitry Shatskiy

Sechenov University, Moscow (Russian Federation)
0 follower

Doctor Adam Goldman

The Chaim Sheba Medical Center, Tel Hashomer (Israel)
0 follower

Doctor Himawan Fernando

The Alfred Hospital, Melbourne (Australia)
0 follower

Mrs Aristi Boulmpou

Hippokration General Hospital of Thessloniki, Thessaloniki (Greece)
0 follower

Mrs Aristi Boulmpou

Hippokration General Hospital of Thessloniki, Thessaloniki (Greece)
0 follower

Doctor Kazuma Oyama

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
0 follower

Doctor Masafumi Kanai

Shinshu University Hospital, Matsumoto (Japan)
0 follower

Doctor Mattia Galli

Catholic University of the Sacred Heart, Rome (Italy)
0 follower

Doctor Sabeeh Shams

Blackpool Teaching Hospitals NHS Trust, Blackpool (United Kingdom of Great Britain & Northern Ireland)
0 follower

Doctor So-Ryoung Lee

Seoul National University Hospital, Seoul (Korea (Republic of))
0 follower

Professor Jan Vaclavik

University Hospital Ostrava, Ostrava (Czechia)
1 follower

This platform is supported by

logo Novo Nordisk